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Abstract: BACKGROUND It is unclear whether cardiopulmonary exercise intolerance in patients with
chronic obstruction of the inferior vena cava (IVC) is reversible following endovascular IVC reconstruc-
tion. METHODS In 17 patients (mean age 45 ± 15 years, 71% men) with post-thrombotic syndrome
due to IVC obstruction and preserved left ventricular ejection fraction (mean 58 ± 3%), we performed
cardiopulmonary exercise testing before and 3 months after IVC reconstruction (mean 4.1 ± 1.5 im-
planted stents). The median time from latest episode of deep vein thrombosis to intervention was 150
(interquartile range 102-820) days. RESULTS At baseline, 12 (71%) patients reported New York Heart
Association (NYHA) class II or III symptoms, 76% did not achieve >85% of predicted oxygen uptake at
peak exercise (mean 61.8 ± 13.7%). After IVC reconstruction, the following changes were observed at
anaerobic threshold: work rate increased by 14.6 W, 95%CI (-0.7; 30.0), oxygen uptake increased by 1.8
ml/kg, 95%CI (0.3; 3.3). Oxygen pulse increased by 1.95 ml per beat, 95%CI (1.12; 2.78), corresponding
to a mean relative increase of 22.5%, 95%CI (12.4; 32.7) (p < 0.001). The following changes were observed
at peak exercise: work rate increased by 48.1 W, 95%CI (27.8; 68.4), oxygen uptake increased by 6.4
ml/kg, 95%CI (3.8; 9.1). Oxygen pulse increased by 2.68 ml per beat, 95%CI (1.60; 3.76), corresponding
to a mean relative increase of 29.4%, 95%CI (17.7; 41.2) (p < 0.001). At follow-up, 5 (29%) patients
remained in NYHA class II. CONCLUSIONS In patients with chronic IVC obstruction, cardiopulmonary
exercise intolerance as a result of impaired cardiac filling is at least partially reversible following endovas-
cular IVC reconstruction. STUDY REGISTRATION URL: https://clinicaltrials.gov. Unique identifier:
NCT02433054.
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A B S T R A C T   
Background: It is unclear whether cardiopulmonary exercise intolerance in patients with chronic obstruction of 
the inferior vena cava (IVC) is reversible following endovascular IVC reconstruction. 
Methods: In 17 patients (mean age 45 ± 15 years, 71% men) with post-thrombotic syndrome due to IVC 
obstruction and preserved left ventricular ejection fraction (mean 58 ± 3%), we performed cardiopulmonary 
exercise testing before and 3 months after IVC reconstruction (mean 4.1 ± 1.5 implanted stents). The median 
time from latest episode of deep vein thrombosis to intervention was 150 (interquartile range 102–820) days. 
Results: At baseline, 12 (71%) patients reported New York Heart Association (NYHA) class II or III symptoms, 
76% did not achieve >85% of predicted oxygen uptake at peak exercise (mean 61.8 ± 13.7%). After IVC 
reconstruction, the following changes were observed at anaerobic threshold: work rate increased by 14.6 W, 95% 
CI (−0.7; 30.0), oxygen uptake increased by 1.8 ml/kg, 95%CI (0.3; 3.3). Oxygen pulse increased by 1.95 ml per 
beat, 95%CI (1.12; 2.78), corresponding to a mean relative increase of 22.5%, 95%CI (12.4; 32.7) (p < 0.001). 
The following changes were observed at peak exercise: work rate increased by 48.1 W, 95%CI (27.8; 68.4), 
oxygen uptake increased by 6.4 ml/kg, 95%CI (3.8; 9.1). Oxygen pulse increased by 2.68 ml per beat, 95%CI 
(1.60; 3.76), corresponding to a mean relative increase of 29.4%, 95%CI (17.7; 41.2) (p < 0.001). At follow-up, 5 
(29%) patients remained in NYHA class II. 
Conclusions: In patients with chronic IVC obstruction, cardiopulmonary exercise intolerance as a result of 
impaired cardiac filling is at least partially reversible following endovascular IVC reconstruction. 
Study registration: URL: https://clinicaltrials.gov. Unique identifier: NCT02433054.   
1. Introduction 
Obstruction of the inferior vena cava (IVC) is a frequent condition 
and is characterized by a wide clinical spectrum, ranging from incidental 
diagnosis to massive bilateral iliofemoral deep vein thrombosis, chronic 
venous insufficiency, or post-thrombotic syndrome (PTS). The majority 
of symptomatic patients complain of disabling venous claudication or 
skin changes caused by chronic elevation of peripheral venous pressure. 
Some patients may experience lumbago or pelvic congestion symptoms, 
caused by venous hypertension in paraspinal or pelvic veins [1]. 
Reasons for IVC occlusion include idiopathic deep vein thrombosis, 
IVC filter thrombosis, inflammatory conditions (e.g. retroperitoneal 
fibrosis), umbilical vein catheters after early birth, or external 
compression syndromes (e.g. tumor, aneurysm). In addition, congenital 
anomalies such as IVC duplication, agenesis with azygos continuation, 
or atresia were occasionally described [2]. 
It remains hypothetical whether a chronic IVC obstruction adversely 
affects venous return to the heart and therefore may cause cardiopul-
monary exercise intolerance [3]. In patients with IVC occlusion, limi-
tations in exercise performance are often attributed to venous 
claudication or muscular deconditioning and not necessarily to impaired 
cardiac preload. First reports of patients with dyspnea on exertion, have 
been described in the context of IVC ligation [4–6]. In smaller case se-
ries, symptomatic patients with IVC ligation were characterized by 
limited increase in cardiac output during exercise assessed by right heart 
catheterization [4], and limited peak oxygen uptake during 
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cardiopulmonary exercise testing [7,8]. These observations suggest but 
do not prove that cardiopulmonary exercise intolerance in patients with 
IVC ligation may be caused by reduced venous return to the heart and its 
incapability to adequately increase stroke volume and cardiac output 
during exercise [3,4,7]. 
Endovascular stent reconstruction of the IVC has emerged as a 
potentially effective treatment for symptomatic patients with PTS, in 
particular in patients who are at risk to develop leg ulcers [9,10]. It is 
unclear whether cardiopulmonary exercise intolerance in patients with 
chronic obstruction of the inferior vena cava (IVC) is reversible 
following endovascular IVC reconstruction. 
2. Methods 
2.1. Patient population 
Patients with chronic IVC obstruction were included in the pro-
spective Swiss Venous stent registry from the university hospitals Zurich 
and Bern, an ongoing clinical study including consecutive adult patients 
treated with dedicated venous nitinol stents for different conditions. 
Main exclusion criteria for enrollment are the inability to provide 
informed consent, age <18 years, pregnancy or postpartum period <30 
days, and an estimated life expectancy <3 month. All patients provided 
written informed consent to participate in the study. 
Between January 2018 and May 2020, 23 patients underwent IVC 
reconstruction for the treatment of the PTS. For this analysis, we 
included consecutive patients who (1) suffered from a PTS or had venous 
leg claudication, (2) had post-thrombotic obstruction of the IVC, (3) had 
left ventricular ejection fraction >50% from a transthoracic echocar-
diogram within 3 months prior to intervention, (4) underwent successful 
endovascular stent reconstruction with patent iliofemoral and caval 
veins at the time of repeated cardiopulmonary exercise test, and (5) had 
cardiopulmonary exercise tests at baseline and 3 months after endo-
vascular intervention. Among the 23 PTS patients with IVC recon-
struction, data from 17 patients was analyzed: 4 were not included 
because they were unable to perform a cardiopulmonary exercise test at 
baseline due to severe venous claudication or physical deconditioning, 1 
patient was unable to tolerate the face mask, and 1 patient had left 
ventricular dysfunction due to congenital heart disease. 
The study was approved by the Swiss Ethics Committee on research 
involving humans and was not funded. The study is registered on the 
National Institutes of Health website (ClinicalTrials.gov; identifier 
NCT02433054). The data that support the findings of this study are 
available from the corresponding author upon reasonable request. 
2.2. Diagnosis of post-thrombotic syndrome, stent reconstruction 
procedure, and postinterventional anticoagulation therapy 
Obstruction of the IVC and iliofemoral veins was diagnosed by 
Duplex ultrasound and confirmed by contrast-enhanced computed to-
mography or magnetic resonance venography. Patients with a Villalta 
score ≥5 points [11] or with symptomatic venous claudication, 
confirmed by treadmill exercise tests, were offered endovascular ther-
apy. Procedural details for IVC stent reconstruction in general anaes-
thesia from our institution were published previously [10]. All patients 
were treated with anticoagulation therapy post intervention for an in-
definite period of time. 
2.3. Clinical follow-up and cardiopulmonary exercise testing 
Routine clinical follow-up visits were performed at our outpatient 
clinic by vascular specialists at 3 months after the intervention. Duplex 
ultrasound was used for investigating stent patency prior to repeated 
cardiopulmonary exercise testing, based on previously published 
criteria [12]. Since 2018, cardiopulmonary exercise tests were routinely 
performed in all patients with IVC obstruction before and after IVC 
reconstruction in our institution. We used a research grade stationary 
system with standard cycle ergometer (Quark CPET®, Cosmed, Italy), as 
previously described [13]. Individualized ramp protocols were designed 
to reach the patients maximal work output between 6 and 12 min, using 
ramp grades between 5 and 20 W per minute at 2-min intervals. 
Continuous cardiopulmonary monitoring facilitated the documentation 
of a 12‑lead electrocardiogram (ECG), cuff blood pressure, and pulse 
oximetry. Respiratory rate, oxygen consumption, tidal volume, carbon 
dioxide production, and power output were measured by a metabolic 
unit. 
Subject effort was defined as sufficient if one of the following in-
dicators was present at peak exercise: 1) achievement of at least 85% of 
predicted maximal heart rate [heart rate / (220 bmp − age) × 100]; 2) a 
respiratory exchange ratio (RER) ≥1.10; and 3) blood serum lactate 
concentration of ≥4.0 mmol/L (if available). Cardiopulmonary func-
tional capacity was graded according to the Ludwigshafen scheme [14]: 
Normal cardiopulmonary capacity was defined as achievement of at 
least 85% of predicted oxygen uptake (VO2) at peak exercise; in patients 
with <85% of predicted VO2 uptake, the extend of impairment was 
graded into mild (70–84%), moderate (50–69%) and severe (<50%). 
We used a 3-criteria approach to identify the anaerobic threshold: (1) 
identification of excess VCO2 relative to VO2 (V-slope), (2) identification 
of hyperventilation relative to oxygen, and (3) exclusion of hyperven-
tilation relative to CO2 at the time point identified by the previous 
criteria [13]. Anaerobic threshold usually occurs at 45–65% of peak VO2 
in healthy untrained subjects. 
Table 1 
Baseline characteristics and procedural details.   
N = 17 
Baseline characteristics  
Age, mean ± SD 45 ± 15 
Women, N (%) 5 (29) 
Known thrombophilia, N (%)a 3 (18) 
Active venous ulcers, N (%) 3 (18) 
Family history of deep vein thrombosis, N (%) 3 (18) 
Current smoking, N (%) 2 (12) 
History of pulmonary embolism, N (%) 2 (12) 
Lupus erythematodes, N (%) 1 (6) 
Diabetes mellitus, N (%) 1 (6) 
Coronary artery disease, N (%) 1 (6) 
Inflammatory bowel disease, N (%) 1 (6) 
Chronic thromboembolic pulmonary disease, N (%) 1 (6) 
History of liver transplantation, N (%) 1 (6) 
Baseline transthoracic echocardiography  
Left ventricular ejection fraction, %, mean ± SD (17/17) 58 ± 3 
Left ventricular end-diastolic dimension, mm, mean ± SD (16/17) 48 ± 5 
Tricuspid annular plane systolic excursion, mm, mean ± SD (15/ 
17) 
20 ± 5 
Right ventricular fractional area change, %, mean ± SD (14/17) 38 ± 3 
Right ventricular end-diastolic dimension, mm, mean ± SD (16/ 
17) 
43 ± 3 
Procedural details  
Number of implanted venous stents, mean ± SD 4.1 ± 1.5 




Distal stent landing zone in infrarenal IVC, N (%) 1 (6) 
Iliac kissing stents, N (%) 15 (88) 
Distal stent landing zone left side in iliac vein/common femoral 
vein, N (%) 
11 (65)/5 
(29) 
Distal stent landing zone right side in iliac vein/common femoral 
vein, N (%) 
7 (41)/8 
(47) 
Anticoagulation therapy: direct oral anticoagulants/vitamin K 
antagonists, N (%) 
11 (65)/6 
(35) 
Data are presented as mean with ± standard deviation or numbers with 
percentages. 
a Two patients had heterozygous factor V Leiden mutation, one patient had 
antiphospholipid antibody syndrome. 
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2.4. Sample size and statistical analysis 
In the absence of data on change of O2 pulse pre and post IVC 
reconstruction, we performed a preliminary analysis of the first 6 pa-
tients, and estimated that we would need 17 patients to demonstrate 
that the O2 pulse at anaerobic threshold would increase after IVC 
reconstruction by 1.5 ml per heartbeat and a standard deviation 2.0, 
with a power 80% power to declare that the mean of the paired differ-
ences is significantly different from zero, i.e. a two-sided p-value is less 
than 0.05. 
Continuous variables are accompanied by the appropriate measure 
of central tendency and dispersion. Categorical variables are reported as 
numbers and percentages. Continuous exercise variables measured pre- 
and post intervention were compared by paired Student t-test and 
accompanied by mean difference with 95% confidence interval (95% 
CI). Skewed data were compared with the Wilcoxon Rank test. A p-value 
<0.05 was considered statistically significant. Statistical analysis was 
performed with jamovi Version 1.2 (The jamovi project, Sydney, 
Australia; https://www.jamovi.org). 
3. Results 
The baseline characteristics of the study population are displayed in 
Table 1. The median time from latest episode of deep vein thrombosis to 
intervention was 150 (interquartile range: 102–820) days. Three pa-
tients had atresia of the IVC, most likely due to umbilical vein catheters 
after premature birth. Two patients had chronic IVC filter thrombosis. 
The filters were extracted prior to IVC reconstruction. 
Two patients had pre-existing cardiopulmonary conditions: one pa-
tient had mild chronic thromboembolic disease without right ventricu-
lar dysfunction or pulmonary hypertension, and one patient had stable 
coronary artery disease with a chronic occlusion of the left circumflex 
artery, preserved left ventricular ejection fraction with lateral hypo-
kinesia. Two patients were treated with angiotensin receptor blockers 
for arterial hypertension, and none received beta blockers or other anti- 
arrhythmic drugs. 
Baseline echocardiography revealed preserved dimension and func-
tion of the left and right ventricles. None had direct or indirect evidence 
of pulmonary hypertension, including paradoxical septal motion, 
tricuspid regurgitation, or elevated right ventricular to right atrial 
pressure gradients. One patient had left ventricular hypertrophy with 
diastolic dysfunction. 
The majority of patients had complex venous stent procedures (mean 
4.1 stents), including reconstruction of the ilio-caval vein confluence 
with kissing stents. Almost half of the patients had overlapping stents 
from the inferior vena cava down to the common femoral vein (Fig. 1). 
All of the 17 patients had patent venous stent implants with <50% 
stent stenosis at the time of repeated cardiopulmonary exercise test. 
Before endovascular intervention, 13 (76%) patients fulfilled at least 
one criteria of sufficient subject effort during cardiopulmonary exercise 
testing: 9 (53%) achieved ≥85% of predicted maximal heart rate, 10 
(59%) showed a respiratory exchange ratio of ≥1.10, and all 7 patients 
with available serum lactate levels showed concentrations ≥4.0 mmol/ 
L. After intervention, 16 (94%) patients fulfilled at least one criteria of 
sufficient subject effort: 13 (76%) patients achieved >85% of predicted 
maximal heart rate, 15 (88%) patients showed a respiratory exchange 
ratio of ≥1.10, and all 4 patients with available serum lactate levels 
showed concentrations ≥4.0 mmol/L. 
3.1. Study outcomes 
At baseline, 13 (76%) patients showed impaired cardiopulmonary 
functional capacity based on the Ludwigshafen scale: 3 (18%) patients 
had mild impairment, 10 (59%) had moderate impairment, and 4 (24%) 
had normal cardiopulmonary capacity. At follow-up, 9 (53%) patients 
showed impaired cardiopulmonary functional capacity: 7 (41%) had 
mild impairment, 2 (12%) had moderate impairment and 8 (47%) 
showed normal cardiopulmonary capacity. 
Fig. 1. Endovascular reconstruction of the inferior vena cava and iliac veins 
with self-expandable nitinol stents. 
Three-dimensional reconstructed computed tomographic image from a patient 
with inferior vena cava reconstruction with self-expandable nitinol stents. The 
proximal stent-landing zone was in the suprarenal inferior vena cava adjacent 
to the right atrium. The patient received iliac kissing stents for reconstructing 
the ilio-caval confluence and stent extensions to both common femoral veins. 
Table 2 































breaths per min 






36.98 ± 9.48 41.62 ± 7.45 4.64 (0.62; 
8.66)  
0.026 
VO2, ml/kg body 
weight 
13.84 ± 4.71 15.64 ± 4.49 1.80 (0.32; 
3.27)  
0.020 









- O2 pulse, ml/ 
beat 
9.25 ± 2.14 11.20 ± 2.52 1.95 (1.12; 
2.78)  
<0.001 
Data are presented as mean with ± standard deviation, and the mean difference 
of the paired samples was calculated with the corresponding 95% confidence 
interval. CI: confidence interval; CPET: cardiopulmonary exercise testing; VO2: 
oxygen consumption; W: Watt. 
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None of the patients had signs of myocardial ischemia during base-
line or follow-up cardiopulmonary exercise testing, including chest pain 
or ECG changes. Systolic blood pressure at peak exercise before and after 
intervention were 168 ± 30 mmHg and 174 ± 35 mmHg (mean differ-
ence: 5.9, 95%CI: −8.7 to 20.5 mmHg), respectively. Diastolic blood 
pressure at peak exercise before and after intervention were 92 ± 17 
mmHg and 90 ± 21 mmHg (mean difference: −1.9, 95%CI: −11.7 to 8 
mmHg), respectively. After IVC reconstruction, the minute ventilation 
(VE) at peak exercise increased from 63.6 ± 17.0 l/min to 83.2 ± 20.8 l/ 
min (mean difference: 19.6, 95%CI: 12.5 to 26.7 l/min), and minute 
ventilation carbon dioxide production relationship (VE/VCO2 slope) 
decreased from 30.2 ± 4.3 to 27.9 ± 4.7 (mean difference: −2.2; 95%CI 
0.5 to −4.9). 
Changes in work rate (WR), heart rate (HR), percent of predicted VO2 
(per kg bodyweight) and O2 pulse (in ml per heartbeat), obtained at the 
time of anaerobic threshold and peak exercise are displayed in 
Tables 2+3 and Figs. 2+3, respectively. Mean increase in O2 pulse at 
anaerobic threshold was 1.95 ml per heartbeat with a standard deviation 
of 1.61, which corresponds to a mean relative increase of 22.5%, 95%CI 
(12.4 to 32.7%; p < 0.001). Mean increase in O2 pulse at peak exercise 
was 2.68 ml per heartbeat with a standard deviation of 2.09, which 
corresponds to a mean relative increase of 29.4%, 95%CI (17.7 to 
41.2%; p < 0.001). 
At baseline, 3 (18%) patients reported New York Heart Association 
(NYHA) class III symptoms, and 9 (53%) class II symptoms. At follow-up, 
no patient was in NYHA class III, and 5 (29%) patients reported class II 
symptoms. 
In the 13 patients with sufficient subject effort, mean increase in O2 
pulse at anaerobic threshold was 1.79 ml per heartbeat with a standard 
deviation of 1.71, which corresponds to a mean relative increase of 
22.3%, 95%CI (8.8 to 35.8%; p = 0.003). Mean increase in O2 pulse at 
peak exercise was 2.36 ml per heartbeat with a standard deviation of 
1.93, which corresponds to a mean relative increase of 27.1%, 95%CI 
(13.2 to 40.9%; p < 0.001). 
4. Discussion 
This is the first study of symptomatic patients with PTS or venous leg 
claudication associated with chronic IVC obstruction who were sys-
tematically evaluated by cardiopulmonary exercise testing before and 
after endovascular reconstruction. First, we found that approximately 
three quarter had NYHA class II or III symptoms and reduced cardio-
pulmonary exercise capacity before IVC reconstruction, despite the 
presence of preserved echocardiographic cardiac function at rest. Sec-
ond, the concept of reversible cardiopulmonary exercise intolerance 
with IVC obstruction due to poor cardiac filling from collateral azygos 
and paravertebral veins confirmed for the first time, by demonstrating 
substantial improvement in O2 pulse at anaerobic threshold, a surrogate 
of cardiac output, within a short period after endovascular IVC recon-
struction. Our results show that cardiopulmonary exercise intolerance 
due to IVC obstruction is at least partially reversible based on a relative 
22.5% increase in O2 pulse at anaerobic threshold, observed after IVC 
reconstruction. The finding of improved cardiac performance paralleled 
a remarkable improvement in NYHA class at the time of the repeated 
cardiopulmonary exercise test. Minimal-invasive catheter-based tech-
niques aiming at increasing the preload reserve may represent a curative 
therapy for patients with chronic IVC obstruction who experience ex-
ertional dyspnea. 
In smaller case series, symptomatic patients with IVC ligation were 
characterized by limited increase in cardiac output during peak exercise 
by right heart catheterization [4], and limited peak oxygen uptake 
during cardiopulmonary exercise testing [7,8]. Measurements at 
anaerobic threshold may better reflect changes in cardiac hemody-
namics in patients with initially low exercise capacity who may expe-
rience an improvement in PTS severity following endovascular 
intervention for two reasons: (1) many PTS patients do not fulfill the 
criteria of sufficient subject effort during cardiopulmonary exercise 
testing as confirmed by our study, (2) recanalization of the IVC is 
associated with improvement in PTS severity and venous claudication 
[10,15,16], and therefore may potentially improve peak exercise per-
formance and VO2 independent from cardiac effects. Of note, we also 
observed a trend towards lower heart rate at anaerobic threshold after 
IVC reconstruction, which is not explainable by a reduction in exercise- 
induced venous claudication. 
To date, the indication for endovascular IVC reconstruction is the 
presence of the PTS, and the presence of cardiopulmonary exercise 
intolerance is not yet considered an indication for revascularization. In a 
recent study of patients with IVC stents, primary and secondary patency 
rates with new-generation nitinol stents at 2 years were 57% and 87%, 
respectively [10]. Stent thrombosis occasionally occurs despite anti-
coagulation therapy, particularly in patients with post-thrombotic 
femoral veins. Nevertheless, there was remarkable improvement in 
PTS severity (Villalta score) and ulcer healing after endovascular IVC 
reconstruction in several studies [10,15,16]. 
Our study has limitations. First, the sample size was small and pa-
tients were followed only for 3 months after endovascular therapy. The 
benefit observed in cardiac hemodynamics and NYHA class remains to 
be confirmed in the long term: we speculate, however, that the benefit 
would persist as long as IVC stents remain patent. Second, we used non- 
invasive gas exchange parameters to assess cardiac function: right heart 
catheterization during exercise would have been helpful to directly 
assess cardiac output and pressures before and after IVC reconstruction. 
Third, 4 of the 17 patients had insufficient subject effort at the baseline 
cardiopulmonary exercise test which could have affected the results of 
our study. When analyzing the 13 patients with sufficient subject effort 
separately, however, we found a similar and significant increase in O2 
pulse at anaerobic threshold and peak exercise. Fourth, limitations of the 
pre-post study design are well known and primarily regard the causal 
effect attributed to the intervention, including unexpected temporal 
changes, regression to the mean, testing threat, and non-specific effects 
of the intervention on the outcome. In this group of patients with 
Table 3 
Cardiopulmonary exercise testing (CPET) parameters at peak exercise.  
CPET parameters 



























breaths per min 






















92.00 ± 16.83 90.12 ±
20.51 
−1.88 
(−11.74; 7.97)  
0.691 
VO2, ml/kg body 
weight 
18.03 ± 5.23 24.46 ± 8.22 6.43 (3.75; 
9.12)  
<0.001 
- VO2, percent 
of predicted 





- O2 pulse, ml/ 
beat 
10.03 ± 2.39 12.71 ± 2.70 2.68 (1.60; 
3.76)  
<0.001 
Data are presented as mean with ± standard deviation, and the mean difference 
of the paired samples was calculated with the corresponding 95% confidence 
interval. BP: blood pressure; CI: confidence interval; CPET: cardiopulmonary 
exercise testing; VO2: oxygen consumption; W: Watt. 
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Fig. 2. Changes in work rate, heart rate, oxygen uptake and oxygen pulse at anaerobic threshold (AT) before and after stent reconstruction of the inferior vena cava. 
Grouped box plots with density curves (Violin plots) display changes in work rate (top left), heart rate (top right), predicted oxygen consumption (bottom left) and 
oxygen pulse (bottom right) at the time of peak exercise. Values derived from cardiopulmonary exercise tests, and were obtained before and after endovascular 
reconstruction of the inferior vena cava. The box plots depict the 95% confidence intervals with mean (μ) and median (horizontal line), while the width of each 
curves corresponds to the frequency of each data point (density). 
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symptomatic PTS and chronic IVC obstruction, we interpreted the 
changes in cardiopulmonary exercise parameters hypothesizing a zero- 
effect. 
In conclusion, we describe a novel form of cardiopulmonary exercise 
intolerance secondary to impaired cardiac filling from chronic IVC 
obstruction. Our results indicate that endovascular IVC reconstruction 
has the potential to improve cardiopulmonary exercise intolerance in 
patients with chronic IVC obstruction. 
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